Literature DB >> 14607883

Prokaryotic expression and antigenic characterization of three recombinant Leishmania antigens for serological diagnosis of canine leishmaniasis.

S Rosati1, M Ortoffi, M Profiti, A Mannelli, W Mignone, E Bollo, L Gradoni.   

Abstract

Three recombinant antigens of Leishmania chagasi (= L. infantum) were expressed in prokaryotic systems and evaluated (using a panel of dog sera characterized by parasitological and serological immunofluorescent antibody test [IFAT] techniques) as diagnostic markers of infection. The whole open reading frame encoding K9, the gene fragment encoding the repetitive sequence of K26, and the 3'-terminal gene fragment encoding a single 39-amino-acid subunit of the kinesin-related protein K39 (K39sub) were amplified from L. infantum DNA and cloned into a pGEX-2T expression vector in frame with glutathione S-transferase (GST). The sensitivity and specificity of enzyme-linked immunosorbent assays (ELISAs) using K26 as an antigen (evaluated with sera from 20 parasitologically positive and 20 parasitologically negative dogs) were both 100% (95% confidence interval [CI] = 83.2 to 100). When K9 and K39sub were used, sensitivity was 95% (95% CI = 75.1 to 99.9) and specificity was 100% (95% CI = 83.2 to 100). Using 182 field sera, a good agreement was found between the recombinant K26 ELISA and IFAT (K = 0.92; 95% CI = 0.86 to 0.98) results and between the K9 and K39sub ELISA (used in parallel) and IFAT (K = 0.87; 95% CI = 0.80 to 0.95) results. The results demonstrate that each antigen carries immunodominant epitopes and that their combination may further increase the sensitivity of currently available serological tests.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607883      PMCID: PMC262443          DOI: 10.1128/cdli.10.6.1153-1156.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  10 in total

Review 1.  The strange case of Leishmania chagasi.

Authors:  I L Maurício; J R Stothard; M A Miles
Journal:  Parasitol Today       Date:  2000-05

Review 2.  Canine leishmaniasis: novel strategies for control.

Authors:  Richard Reithinger; Clive R Davies
Journal:  Trends Parasitol       Date:  2002-07

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi.

Authors:  A Bhatia; N S Daifalla; S Jen; R Badaro; S G Reed; Y A Skeiky
Journal:  Mol Biochem Parasitol       Date:  1999-08-20       Impact factor: 1.759

5.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

Review 6.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

7.  Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.

Authors:  A Scalone; R De Luna; G Oliva; L Baldi; G Satta; G Vesco; W Mignone; C Turilli; R R Mondesire; D Simpson; A R Donoghue; G R Frank; L Gradoni
Journal:  Vet Parasitol       Date:  2002-04-02       Impact factor: 2.738

8.  rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.

Authors:  E E Zijlstra; N S Daifalla; P A Kager; E A Khalil; A M El-Hassan; S G Reed; H W Ghalib
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.

Authors:  J M Burns; W G Shreffler; D R Benson; H W Ghalib; R Badaro; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Serological diagnosis of leishmaniasis: on detecting infection as well as disease.

Authors:  C Dye; E Vidor; J Dereure
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

  10 in total
  14 in total

1.  Chicken antibodies: a useful tool for antigen capture ELISA to detect bovine leukaemia virus without cross-reaction with other mammalian antibodies.

Authors:  M Juliarena; S Gutierrez; C Ceriani
Journal:  Vet Res Commun       Date:  2006-12-22       Impact factor: 2.459

2.  Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India.

Authors:  M Vaish; A Bhatia; S G Reed; J Chakravarty; S Sundar
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

3.  Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.

Authors:  A Boarino; A Scalone; L Gradoni; E Ferroglio; F Vitale; R Zanatta; M G Giuffrida; S Rosati
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.

Authors:  Robert Andreata-Santos; Rafael Rahal Guaragna Machado; Rúbens Prince Dos Santos Alves; Natiely Silva Sales; Camila Pereira Soares; Karine Bitencourt Rodrigues; Mariângela Oliveira Silva; Marianna Teixeira de Pinho Favaro; Mônica Josiane Rodrigues-Jesus; Márcio Massao Yamamoto; Juliana Bannwart de Andrade; Ricardo Ambrósio Fock; Paulo Francisco Ramos Margarido; Cristiane Rodrigues Guzzo Carvalho; Silvia Beatriz Boscardin; Edison Luiz Durigon; Luís C S Ferreira
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

5.  Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.

Authors:  Sowmya Pattabhi; Jacqueline Whittle; Raodoh Mohamath; Sayda El-Safi; Garner G Moulton; Jeffrey A Guderian; Danny Colombara; Asem O Abdoon; Maowia M Mukhtar; Dinesh Mondal; Javan Esfandiari; Shailendra Kumar; Peter Chun; Steven G Reed; Ajay Bhatia
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

6.  Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.

Authors:  D Talmi-Frank; D Strauss-Ayali; C L Jaffe; G Baneth
Journal:  Clin Vaccine Immunol       Date:  2006-02

7.  Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis.

Authors:  Isaac Queiroz de Oliveira; Rodrigo Araujo Silva; Michel Vergne Sucupira; Edmilson Domingos da Silva; Alexandre Barbosa Reis; Gabriel Grimaldi; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Parasit Vectors       Date:  2015-01-24       Impact factor: 3.876

8.  Evaluation of a new set of recombinant antigens for the serological diagnosis of human and canine visceral leishmaniasis.

Authors:  Franklin B Magalhães; Artur L Castro Neto; Marilia B Nascimento; Wagner J T Santos; Zulma M Medeiros; Adelino S Lima Neto; Dorcas L Costa; Carlos H N Costa; Washington L C Dos Santos; Lain C Pontes de Carvalho; Geraldo G S Oliveira; Osvaldo P de Melo Neto
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

9.  Polymorphism in the HASPB repeat region of East African Leishmania donovani strains.

Authors:  Arie Zackay; Abdelmajeed Nasereddin; Yegnasew Takele; Dagimawie Tadesse; Workagegnehu Hailu; Zewdu Hurissa; Sisay Yifru; Teklu Weldegebreal; Ermias Diro; Aysheshm Kassahun; Asrat Hailu; Charles L Jaffe
Journal:  PLoS Negl Trop Dis       Date:  2013-01-24

10.  Evaluation of rK39 rapid diagnostic tests for canine visceral leishmaniasis: longitudinal study and meta-analysis.

Authors:  Rupert J Quinnell; Connor Carson; Richard Reithinger; Lourdes M Garcez; Orin Courtenay
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.